Download PDF

1. Company Snapshot

1.a. Company Description

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate.As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders.


As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

Show Full description

1.b. Last Insights on VTR

Ventas' recent momentum is driven by its expanding SHOP footprint, rising cash NOI, and active capital recycling. The company's strong Q4 FFO results, with higher FFO and revenues, were fueled by gains in SHOP and OM&R, offsetting a dip in triple-net results. According to Marketbeat, Ventas has earned an average recommendation of "Moderate Buy" from 17 research firms, with 14 analysts assigning a buy rating.

1.c. Company Highlights

2. Ventas Q1 2026: Senior Housing Surge Drives Strong Growth

Ventas, Inc. delivered a robust first‑quarter, reporting a 9% YoY increase in same‑store property NOI and normalized FFO per share of $0.94, up 9% from the prior year. Revenue rose 7.8%, while operating margin edged up to 12.5%. EPS came in at $0.12 versus the consensus estimate of $0.1229¹, reflecting disciplined cost control amid a 15% NOI surge in its Senior Housing Operating Portfolio (SHOP). The stock trades at a P/E of 160.52 and a P/B of 3.19, indicating a premium for its high‑margin senior housing pipeline.

Publication Date: May -05

📋 Highlights
  • Strong Q1 Growth:: 9% YoY increase in same-store property NOI and normalized FFO per share of $0.94, up 9% YoY.
  • SHOP Portfolio Performance:: 15% YoY NOI growth and U.S. occupancy rose 370 bps to 90.7%.
  • Full-Year Guidance Raise:: FFO per share mid-guidance increased by $0.03 to $3.86, driven by 16% SHOP same-store growth.
  • Investment Momentum:: Closed $1.7B in senior housing investments; 2026 guidance raised to $3B; $5.5B liquidity available.
  • Occupancy & Margin Potential:: SHOP portfolio occupancy at 90.4%, with U.S. occupancy at 87%, targeting 100% and 70% incremental margins above 90% occupancy.

Earnings Snapshot

First‑quarter revenue reached $1.38 billion, a 7.8% year‑over‑year gain, driven by a 15% rise in NOI from SHOP and a 370‑basis‑point bump in U.S. occupancy. Operating margin expanded to 12.5% as fixed costs remained stable. The normalized FFO per share of $0.94 reflects strong cash generation, with free‑cash‑flow yield at 1.12%.

Senior Housing Momentum

SHOP now accounts for 60% of the business, serving nearly 100,000 residents. U.S. occupancy climbed to 90.7% and overall occupancy to 90.4%. The portfolio’s unlevered IRR remains in the double‑digit to mid‑teens range, and incremental margins hover around 50% for communities above 90% occupancy.

Guidance Upswing

Ventas raised its full‑year FFO guidance to $3.86 per share, up $0.03, anchored by a projected 16% same‑store growth in SHOP. The company now expects 2026 investment volume of $3 billion, reflecting confidence in a demographic‑driven demand cycle and a robust acquisition pipeline.

Capital Deployment & Liquidity

The firm closed $1.7 billion of senior housing investments this year and has a $5.5 billion liquidity cushion. Net debt/EBITDA sits at 5.11, and the company’s strong cash position supports continued capital deployment while preserving financial flexibility.

Strategic Initiatives & Outlook

Ventas’s OI platform fuels operator scale, and the Revel joint‑venture showcases high‑quality assets with an all‑in cap rate near 6.5%. The company targets double‑digit NOI growth, aiming to double its $50 million run‑rate to $100 million. With a 2.23% dividend yield and a 3.12% ROIC, the outlook remains positive amid a fragmented senior housing market.

3. NewsRoom

Card image cap

REITs Excel, Earnings Swell, Fed Rebels

May -03

Source: seekingalpha.com

Card image cap

Welltower's Q1 FFO Beat Estimates on Strong SHO NOI Growth

Apr -29

Source: zacks.com

Card image cap

Ventas, Inc. (VTR) Q1 2026 Earnings Call Transcript

Apr -28

Source: seekingalpha.com

Card image cap

Ventas Q1 FFO & Revenues Beat Estimates on Strong SHOP Results

Apr -28

Source: zacks.com

Card image cap

Ventas: Senior Housing Growth Appears Priced In

Apr -28

Source: seekingalpha.com

Card image cap

Here's What Key Metrics Tell Us About Ventas (VTR) Q1 Earnings

Apr -27

Source: zacks.com

Card image cap

Ventas (VTR) Q1 FFO and Revenues Beat Estimates

Apr -27

Source: zacks.com

Card image cap

Ventas Reports 2026 First Quarter Results

Apr -27

Source: businesswire.com

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (4.65%)

6. Segments

Senior Housing Operating Portfolio

Expected Growth: 4.5%

Ventas' Senior Housing Operating Portfolio growth of 4.5% is driven by increasing demand for senior living communities, driven by demographics (aging population), need for healthcare services, and rising acuity levels. Additionally, strategic partnerships, investments in technology, and operational efficiencies contribute to the growth.

Outpatient Medical and Research Portfolio

Expected Growth: 4.8%

Ventas' Outpatient Medical and Research Portfolio growth of 4.8% is driven by increasing demand for outpatient services, expansion of healthcare networks, and investments in medical research facilities. Additionally, the shift towards value-based care and aging population demographics contribute to the segment's growth.

Triple-Net Leased Properties

Expected Growth: 5.2%

Ventas, Inc.'s 5.2% growth in Triple-Net Leased Properties is driven by increasing demand for healthcare services, aging population, and strategic acquisitions. Additionally, the company's diversified portfolio, strong tenant credit, and long-term leases contribute to stable cash flows and growth. Furthermore, Ventas' focus on high-quality properties and proactive asset management also support the segment's growth.

Non-Segment

Expected Growth: 4.2%

Ventas, Inc.'s Non-Segment growth of 4.2% is driven by strategic investments in healthcare technology, expansion of medical office buildings, and increasing demand for senior housing. Additionally, the company's focus on diversifying its portfolio and strengthening its balance sheet has contributed to this growth.

7. Detailed Products

Senior Housing

Ventas, Inc. owns and operates senior housing communities that provide independent living, assisted living, and memory care services to seniors.

Medical Office Buildings

Ventas, Inc. owns and operates medical office buildings that provide healthcare services, including outpatient surgery, imaging, and physician practices.

Life Science Properties

Ventas, Inc. owns and operates life science properties that provide laboratory and research space for biotechnology, pharmaceutical, and medical device companies.

Hospital Investments

Ventas, Inc. owns and operates hospitals that provide acute care services, including emergency department, surgical, and rehabilitation services.

Outpatient Facilities

Ventas, Inc. owns and operates outpatient facilities that provide services such as ambulatory surgery, imaging, and physical therapy.

8. Ventas, Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

Ventas, Inc. operates in a highly competitive industry, but the threat of substitutes is mitigated by the company's diversified portfolio of healthcare properties and its ability to adapt to changing market trends.

Bargaining Power Of Customers

Ventas, Inc.'s customers, primarily healthcare providers, have limited bargaining power due to the company's strong market position and the lack of alternative options for healthcare properties.

Bargaining Power Of Suppliers

Ventas, Inc. relies on a diverse range of suppliers for its operations, but the bargaining power of suppliers is moderate due to the company's scale and negotiating power.

Threat Of New Entrants

The threat of new entrants is low for Ventas, Inc. due to the high barriers to entry in the healthcare real estate industry, including significant capital requirements and regulatory hurdles.

Intensity Of Rivalry

The healthcare real estate industry is highly competitive, with several large players competing for market share, driving up the intensity of rivalry for Ventas, Inc.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 58.71%
Debt Cost 4.72%
Equity Weight 41.29%
Equity Cost 10.21%
WACC 6.99%
Leverage 142.19%

11. Quality Control: Ventas, Inc. passed 2 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
CareTrust REIT

A-Score: 7.1/10

Value: 2.5

Growth: 3.9

Quality: 8.3

Yield: 9.0

Momentum: 9.0

Volatility: 10.0

1-Year Total Return ->

View Full Report
Stock-Card
Omega Healthcare

A-Score: 6.9/10

Value: 2.9

Growth: 3.0

Quality: 7.3

Yield: 10.0

Momentum: 8.0

Volatility: 10.0

1-Year Total Return ->

View Full Report
Stock-Card
Sabra Health Care REIT

A-Score: 6.8/10

Value: 4.0

Growth: 3.4

Quality: 6.8

Yield: 10.0

Momentum: 7.0

Volatility: 9.7

1-Year Total Return ->

View Full Report
Stock-Card
Healthcare Realty Trust

A-Score: 6.4/10

Value: 5.9

Growth: 2.9

Quality: 5.4

Yield: 10.0

Momentum: 5.5

Volatility: 9.0

1-Year Total Return ->

View Full Report
Stock-Card
Medical Properties Trust

A-Score: 5.7/10

Value: 6.9

Growth: 0.9

Quality: 4.4

Yield: 10.0

Momentum: 8.0

Volatility: 4.0

1-Year Total Return ->

View Full Report
Stock-Card
Ventas

A-Score: 5.6/10

Value: 1.4

Growth: 3.6

Quality: 3.2

Yield: 7.0

Momentum: 9.0

Volatility: 9.7

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

87.26$

Current Price

87.26$

Potential

-0.00%

Expected Cash-Flows